Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TRAX

First Tracks Biotherapeutics Inc

Apr 22 • 04:00PM ET

18.87

+1.87 11.00 %

Healthcare • Biotechnology • USA • NASD

Held by: XBI IWM IWO IBB FYC SCHA FYX IWC VFMO FSMD

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	-	Perf Week	-23.14%
Market Cap	-	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-0.68%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	26.80 -29.59%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	14.79 27.59%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	23.57% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	2.90	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	-12.70%	Beta	-	Target Price	42.50
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-12.70%	Rel Volume	5.00	Prev Close	17.00
Employees	-	LT Debt/Eq	-	Earnings	-	SMA200	-12.70%	Avg Volume	168.82K	Price	18.87
IPO	Apr 06, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	843,418	Change	11.00%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Initiated	Barclays	Overweight	$40
Apr-21-26	Initiated	UBS	Buy	$45

Apr-20-26 09:15AM

First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases

(GlobeNewswire) -17.37%

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)